2002
DOI: 10.1097/00000539-200209000-00009
|View full text |Cite
|
Sign up to set email alerts
|

Anesthesia for a Patient with Catecholaminergic Polymorphic Ventricular Tachycardia

Abstract: A patient with catecholaminergic polymorphic ventricular tachycardia required anesthesia for implantation of a defibrillator. The diagnostic criteria, treatment, and anesthetic considerations for this rare, familial dysrhythmia are described.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
9
0

Year Published

2005
2005
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 8 publications
0
9
0
Order By: Relevance
“… 6 Therefore, methods are needed to blunt the effect of catecholamines. Guidelines for treating patients with CPVT recommend various therapeutic options, 7 , 8 and patients diagnosed with CPVT require lifestyle changes that limit or avoid competitive sports or stressful environments. 7 , 8 In addition, beta‐adrenergic receptor blockers (BB) are recommended as the primary treatment for all symptomatic patients, and adding flecainide, a sodium‐channel blocker, to BB may be useful.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“… 6 Therefore, methods are needed to blunt the effect of catecholamines. Guidelines for treating patients with CPVT recommend various therapeutic options, 7 , 8 and patients diagnosed with CPVT require lifestyle changes that limit or avoid competitive sports or stressful environments. 7 , 8 In addition, beta‐adrenergic receptor blockers (BB) are recommended as the primary treatment for all symptomatic patients, and adding flecainide, a sodium‐channel blocker, to BB may be useful.…”
Section: Discussionmentioning
confidence: 99%
“…Guidelines for treating patients with CPVT recommend various therapeutic options, 7 , 8 and patients diagnosed with CPVT require lifestyle changes that limit or avoid competitive sports or stressful environments. 7 , 8 In addition, beta‐adrenergic receptor blockers (BB) are recommended as the primary treatment for all symptomatic patients, and adding flecainide, a sodium‐channel blocker, to BB may be useful. 7 The guideline recommends LCSD if patients are intolerant to or have a contraindication to this first‐line BB medication and if recurrent syncope or VT or several implantable cardioverter defibrillator (ICD) shocks occur, despite continued medication.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…During the post-cardiac arrest care of CPVT patients, the administration of β-adrenergic agonists should still be avoided [ 10 ]. Vasopressors with pure α-adrenergic activity, such as phenylephrine, are safer for the treatment of hypotension in these patients [ 10 ].…”
Section: Discussionmentioning
confidence: 99%